Literature DB >> 20570099

Cemented total hip arthroplasty with transverse subtrochanteric shortening osteotomy for Crowe group IV dislocated hip.

Toshiyuki Kawai1, Chiaki Tanaka, Minoru Ikenaga, Hiroshi Kanoe.   

Abstract

A consecutive series of 19 cemented total hip arthroplasties with transverse subtrochanteric shortening osteotomy was performed for Crowe group IV hip, with a mean follow-up of 38 (6-96) months. The osteotomy sites were covered with onlay grafts of the excised fragments. The conditions of the osteotomy sites were classified into 3 types according to the presence of a remaining gap and cement interposition within it. Three cases had a noticeable gap, and 2 of them showed cement interposition. All osteotomy sites became united involving the onlay grafts, with an average time to union of 4.9 (3-8) months. Our findings suggest that cemented total hip arthroplasty with subtrochanteric transverse osteotomy provides satisfactory short-term results without major complications for Crowe group IV hip.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20570099     DOI: 10.1016/j.arth.2010.03.029

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  11 in total

Review 1.  Current concept in dysplastic hip arthroplasty: Techniques for acetabular and femoral reconstruction.

Authors:  Goran Bicanic; Katarina Barbaric; Ivan Bohacek; Ana Aljinovic; Domagoj Delimar
Journal:  World J Orthop       Date:  2014-09-18

2.  Subtrochanteric shortening osteotomy combined with cemented total hip arthroplasty for Crowe group IV hips.

Authors:  Kenichi Oe; Hirokazu Iida; Tomohisa Nakamura; Naofumi Okamoto; Takahiko Wada
Journal:  Arch Orthop Trauma Surg       Date:  2013-12       Impact factor: 3.067

3.  Total hip arthroplasty for Crowe IV hip without subtrochanteric shortening osteotomy -a long term follow up study.

Authors:  Toshiyuki Kawai; Chiaki Tanaka; Hiroshi Kanoe
Journal:  BMC Musculoskelet Disord       Date:  2014-03-10       Impact factor: 2.362

4.  Comparison of transverse and modified subtrochanteric femoral shortening osteotomy in total hip arthroplasty for developmental dysplasia of hip: a meta-analysis.

Authors:  Changchuan Li; Chi Zhang; Maolin Zhang; Yue Ding
Journal:  BMC Musculoskelet Disord       Date:  2014-10-03       Impact factor: 2.362

5.  Tibial lengthening for unilateral Crowe type-IV developmental dysplasia of the hip.

Authors:  Jun Wan; Xiang-Sheng Zhang; Lin Ling; Jing Fan; Zhi-Hong Li
Journal:  Indian J Orthop       Date:  2014-07       Impact factor: 1.251

6.  Is pseudoacetabulum an important factor determining SSTO application in total hip arthroplasty for Crowe IV hips? a retrospective cohort study.

Authors:  Haiwen Peng; Guoqiang Zhang; Chi Xu; Tianhao Wang; Yan Wang
Journal:  J Orthop Surg Res       Date:  2019-07-03       Impact factor: 2.359

7.  Optimal location of subtrochanteric osteotomy in total hip arthroplasty for crowe type IV developmental dysplasia of hip.

Authors:  Zhe-Yu Huang; Hua Liu; Ming Li; Jing Ling; Jun-Hui Zhang; Zhi-Min Zeng
Journal:  BMC Musculoskelet Disord       Date:  2020-04-06       Impact factor: 2.362

8.  Leg lengthening of more than 5 cm is a risk factor for sciatic nerve injury after total hip arthroplasty for adult hip dislocation.

Authors:  Yoshitoshi Higuchi; Yukiharu Hasegawa; Naoki Ishiguro
Journal:  Nagoya J Med Sci       Date:  2015-08       Impact factor: 1.131

9.  Subtrochanteric femoral shortening osteotomy concomitantly performed with revision total hip arthroplasty: A case report.

Authors:  Yu Takeda; Shigeo Fukunishi; Shoji Nishio; Yuki Fujihara; Shinichi Yoshiya
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

10.  Total Hip Arthroplasty Combined With Subtrochanteric Transverse Shortening Osteotomy: Factors Associated With Delayed Union at the Osteotomy Site.

Authors:  Toshiyuki Kawai; Koji Goto; Yutaka Kuroda; Shuichi Matsuda
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.